{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:49:26Z","timestamp":1791618566997,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1053\/j.jvca.2024.12.001","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T02:36:17Z","timestamp":1733366177000},"page":"447-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Performance of Hemochron ACT-LR and ACT+ Test Cuvettes in Monitoring Low to Moderate Heparin Concentrations: An In Vitro Study"],"prefix":"10.1053","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6449-4734","authenticated-orcid":false,"given":"Janne","family":"Moilanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Ohtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Kaakinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Pokela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva-Riitta","family":"Savolainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Erkinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2024.12.001_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1051\/ject\/201244015","article-title":"Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution","volume":"44","author":"Ojito","year":"2012","journal-title":"J Extracorp Technol"},{"key":"10.1053\/j.jvca.2024.12.001_bib0002","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12871-019-0846-z","article-title":"Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: Agreement, concordance, and clinical reliability","volume":"19","author":"Dirkmann","year":"2019","journal-title":"BMC Anesthesiol"},{"key":"10.1053\/j.jvca.2024.12.001_bib0003","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1051\/ject\/202052212","article-title":"Can we rely on the activated clotting time to measure heparin anticoagulation? A clinical evaluation of two ACT monitors","volume":"52","author":"Nilsson","year":"2020","journal-title":"J Extracorp Technol"},{"key":"10.1053\/j.jvca.2024.12.001_bib0004","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1053\/j.jvca.2018.01.027","article-title":"Assessment of heparin anticoagulation measured using i-STAT and Hemochron activated clotting time","volume":"32","author":"Maslow","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.001_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/bja\/ael194","article-title":"Anticoagulation monitoring during vascular surgery: Accuracy of the Hemochron\u00ae low range activated clotting time (ACT-LR)","volume":"97","author":"Tremey","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2024.12.001_bib0006","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/POC.0b013e3182a1a54c","article-title":"Relationship of activated clotting time to heparin dose depends on the type of cuvette used with the Hemochron Signature Elite","volume":"12","author":"Senzel","year":"2013","journal-title":"Point of Care"},{"key":"10.1053\/j.jvca.2024.12.001_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bpa.2016.07.002","article-title":"Anticoagulation management during cross-clamping and bypass","volume":"30","author":"Lander","year":"2016","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1053\/j.jvca.2024.12.001_bib0008","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","article-title":"Heparin sensitivity and resistance","volume":"116","author":"Finley","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.12.001_bib0009","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1515\/cclm-2013-0278","article-title":"A novel method for the direct determination of heparin concentration during cardiopulmonary bypass surgery","volume":"51","author":"Haselbach","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.jvca.2024.12.001_bib0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11239-022-02672-y","article-title":"Activated clotting time in inpatient diagnostic and interventional settings","volume":"54","author":"Dalton","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2024.12.001_bib0011","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH08-08-0528","article-title":"Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation","volume":"101","author":"Chia","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2024.12.001_bib0012","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/diagnostics13081489","article-title":"Laboratory assessment of unfractionated heparin (UFH) with activated clotting time (ACT) and anti-Xa activity during peripheral arterial angiographic procedure","volume":"13","author":"Helin","year":"2023","journal-title":"Diagnostics"},{"key":"10.1053\/j.jvca.2024.12.001_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1076029620975494","article-title":"Activated clotting time (ACT) for monitoring of low-dose heparin: Performance characteristics in healthy adults and critically ill patients","volume":"26","author":"Wehner","year":"2020","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"10.1053\/j.jvca.2024.12.001_bib0014","unstructured":"Gray E, Hogwood J, Rigsby P, et al. An international collaborative study to value assign the 6th [sixth] International Standard for Unfractionated Heparin and the US Pharmacopeial Heparin Reference Standard for Assay Lot F. 2009. https:\/\/iris.who.int\/handle\/10665\/70134"},{"key":"10.1053\/j.jvca.2024.12.001_bib0015","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.jvca.2021.05.021","article-title":"The Standard Point-of-Care Hemochron Jr. ACT+ test in monitoring heparin administration for cardiopulmonary bypass in severe factor XII deficiency","volume":"36","author":"Erkinaro","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.001_bib0016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"327","author":"Martin Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2024.12.001_bib0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-1681.1997.tb01807.x","article-title":"Comparing methods of measurements","volume":"24","author":"Ludbrook","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1053\/j.jvca.2024.12.001_bib0018","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/bja\/aem214","article-title":"Using the Bland-Altman method to measure agreement with repeated measures","volume":"99","author":"Myles","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2024.12.001_bib0019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"10.1053\/j.jvca.2024.12.001_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1053\/j.jvca.2024.12.001_bib0021","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0962280211402548","article-title":"Confidence interval estimation for the Bland-Altman limits of agreement with multiple observations per individual","volume":"22","author":"Zou","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"10.1053\/j.jvca.2024.12.001_bib0022","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11239-009-0391-6","article-title":"Monitoring unfractionated heparin in pediatric patients with congenital heart disease having cardiac catheterization or cardiac surgery","volume":"29","author":"Kim","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2024.12.001_bib0023","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jvs.2017.11.079","article-title":"Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure","volume":"68","author":"Dieplinger","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.jvca.2024.12.001_bib0024","unstructured":"Budd JR, Durham PA, Gwise TE, et al. Measurement Procedure Comparison and Bias Estimation Using Patient Samples; Approved Guideline-Third Edition. CLSI; 2013."},{"key":"10.1053\/j.jvca.2024.12.001_bib0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1525-1594.2000.06552.x","article-title":"Effect of heparin, platelets, activated platelets, platelet fragments, and hematocrit on activated clotting time","volume":"24","author":"Girardi","year":"2000","journal-title":"Artif Organs"},{"key":"10.1053\/j.jvca.2024.12.001_bib0026","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","article-title":"Heparin sensitivity and resistance","volume":"116","author":"Finley","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.12.001_bib0027","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/0267659117692661","article-title":"Changes in heparin dose response slope during cardiac surgery: Possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT","volume":"32","author":"Ichikawa","year":"2017","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2024.12.001_bib0028","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1213\/ANE.0b013e3181ce1ffa","article-title":"Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations","volume":"111","author":"Garvin","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.12.001_bib0029","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1053\/j.jvca.2022.06.021","article-title":"Heparin resistance during cardiopulmonary bypass in adult cardiac surgery","volume":"36","author":"Chen","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702400939X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702400939X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T13:16:22Z","timestamp":1738847782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105307702400939X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S105307702400939X"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.12.001","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of Hemochron ACT-LR and ACT+ Test Cuvettes in Monitoring Low to Moderate Heparin Concentrations: An In Vitro Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}